Albert D. Dyrness - May 30, 2023 Form 4 Insider Report for Sonnet BioTherapeutics Holdings, Inc. (SONN)

Role
Director
Signature
/s/ John Harry Cross III, power of attorney
Stock symbol
SONN
Transactions as of
May 30, 2023
Transactions value $
$10,883
Form type
4
Date filed
5/31/2023, 08:30 AM
Previous filing
Dec 22, 2022
Next filing
Dec 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SONN Common Stock Purchase $10.9K +23.3K +407.48% $0.47 29K May 30, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes unvested RSUs.